As of 2025-09-16, the Relative Valuation of Intellia Therapeutics Inc (NTLA) is (66.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.57 USD, the upside of Intellia Therapeutics Inc based on Relative Valuation is -672.2%.
The range of the Relative Valuation is (62.98) - (69.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 15.5x | 14.8x |
| Forward P/E multiples | 14.0x - 15.6x | 14.8x |
| Fair Price | (62.98) - (69.42) | (66.20) |
| Upside | -644.4% - -700.0% | -672.2% |
| Date | P/E |
| 2025-09-15 | -2.59 |
| 2025-09-12 | -2.55 |
| 2025-09-11 | -2.55 |
| 2025-09-10 | -2.52 |
| 2025-09-09 | -2.66 |
| 2025-09-08 | -2.65 |
| 2025-09-05 | -2.70 |
| 2025-09-04 | -2.60 |
| 2025-09-03 | -2.62 |
| 2025-09-02 | -2.55 |
| 2025-08-29 | -2.54 |
| 2025-08-28 | -2.59 |
| 2025-08-27 | -2.55 |
| 2025-08-26 | -2.54 |
| 2025-08-25 | -2.54 |
| 2025-08-22 | -2.35 |
| 2025-08-21 | -2.26 |
| 2025-08-20 | -2.28 |
| 2025-08-19 | -2.30 |
| 2025-08-18 | -2.40 |
| 2025-08-15 | -2.46 |
| 2025-08-14 | -2.44 |
| 2025-08-13 | -2.46 |
| 2025-08-12 | -2.43 |
| 2025-08-11 | -2.40 |
| 2025-08-08 | -2.41 |
| 2025-08-07 | -2.56 |
| 2025-08-06 | -2.54 |
| 2025-08-05 | -2.59 |
| 2025-08-04 | -2.71 |
| 2025-08-01 | -2.57 |
| 2025-07-31 | -2.60 |
| 2025-07-30 | -2.76 |
| 2025-07-29 | -2.79 |
| 2025-07-28 | -2.93 |
| 2025-07-25 | -3.04 |
| 2025-07-24 | -2.86 |
| 2025-07-23 | -3.18 |
| 2025-07-22 | -3.02 |
| 2025-07-21 | -2.82 |
| 2025-07-18 | -2.70 |
| 2025-07-17 | -2.64 |
| 2025-07-16 | -2.67 |
| 2025-07-15 | -2.57 |
| 2025-07-14 | -2.67 |
| 2025-07-11 | -2.58 |
| 2025-07-10 | -2.72 |
| 2025-07-09 | -2.71 |
| 2025-07-08 | -2.49 |
| 2025-07-07 | -2.29 |